Pancreas transplantation: An overview

Transplantation Reviews

Volumn 18, Issue 1, 2004, Pages 1-9

  Di Carlo, Antonio ^a,b   Odorico, John S ^a   Sollinger, Hans W ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; C PEPTIDE; CALCINEURIN INHIBITOR; DACLIZUMAB; GLUCOSE; HEPARIN; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ANASTOMOSIS LEAKAGE; CADAVER DONOR; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; EXOCRINE SECRETION; GLUCOSE METABOLISM; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERINSULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; MORTALITY; NEPHROTOXICITY; NONHUMAN; ORGAN DONOR; PANCREAS TRANSPLANTATION; PANCREATITIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; QUALITY OF LIFE; RECIPIENT; REVIEW; SIDE EFFECT; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT INDICATION; VEIN BLOOD FLOW;

EID: 2942592836     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2003.11.001     Document Type: Article

References (94)

1. Banting FG, Best C: The internal secretion of the pancreas. J Lab Clin Med 1922, 7:256
2. Kelly WD, Lillehei RC, Merkel FK, et al: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967, 61:827
3. Gruessner AC, Sutherland DER: Pancreas Transplant Outcomes for United States (US) and Non-US Cases as Reported to the United Network for Organ Sharing (UNOS) and to the International Pancreas Transplant Registry (IPTR) as of October 2002, in: Terasaki PI (ed): Clinical Transplants 2002, Vol. 41. Los Angeles, CA, UCLA Immunogenetics Center, 2003, p77
4. Sollinger HW, Odorico JS, Knechtle SJ, et al: Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998, 228:284
5. Sutherland DE, Gruessner RW, Dunn DL, et al: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001, 233:463
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329: 977
7. Tyden G, Bolinder J, Brattstrom C, et al: Long-term metabolic control in recipients of segmental or whole-organ pancreatic grafts with enteric exocrine diversion and function beyond 5 years. Transplant Proc 1998, 30:634
8. Tajra LC, Martin X, Benchaid M, et al: Long-term metabolic control in pancreas transplant patients according to three techniques. Transplant Proc 1998, 30:268
9. Nauck M, Busing M, Siegel EG, et al: Consequences of systemic venous drainage and denervation of heterotopic pancreatic transplants for insulin/C-peptide profiles in the basal state and after oral glucose. Diabetologia 1991, 34:S81 (Suppl)
10. Diem P, Redmon JB, Abid M, et al: Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990, 86:2008
11. Barrou Z, Seaquist ER, Robertson RP: Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes 1994, 43:661
12. Kendall DM, Rooney DP, Smets YF, et al: Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997, 46:249
13. Mayes JT, Cennis VW, Hoogwerf BJ: Pancreas transplantation in type 1 diabetes: Hope vs reality. Cleve Clin J Med 2000, 67:281
14. Douzdjian V, Rice JC, Gugliuzza KK, et al: Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients. Am J Kidney Dis 1996, 27:106
15. Smets YF, Westendorp RG, van der Pijl JW, et al: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999, 353:1915
16. Becker BN, Brazy PC, Becker YT, et al: Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000, 57:2129
17. Reddy KS, Stablein D, Taranto S, et al: Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003, 41:464
18. Tyden G, Bolinder J, Solders G, et al: Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999, 67:645
19. Manske CL, Wang Y, Rector T, et al: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992, 340:998
20. Gaber AO, el-Gebely S, Sugathan P, et al: Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients. Transplantation 1995, 59: 1105
21. Gaber AO, el-Gebely S, Sugathan P, et al: Changes in cardiac function of type I diabetics following pancreas-kidney and kidney-alone transplantation. Transplant Proc 1995, 27:1322
22. Jukema JW, Smets YF, van der Pijl JW, et al: Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type I diabetes. Diabetes Care 2002, 25:906
23. Larsen JL, Ratanasuwan T, Burkman T, et al: Carotid intima media thickness decreases after pancreas transplantation. Transplantation 2002, 73:936
24. White SA, Nicholson ML, London NJ: Vascularized pancreas allotransplantation-clinical indications and outcome. Diabet Med 1999, 16:533
25. Sung RS, Althoen M, Howell TA, et al: Peripheral vascular occlusive disease in renal transplant recipients: Risk factors and impact on kidney allograft survival. Transplantation 2000, 70:1049
26. Morrissey PE, Shaffer D, Monaco AP, et al: Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease. Arch Surg 1997, 132: 358
27. Kalker AJ, Pirsch JD, Heisey D, et al: Foot problems in the diabetic transplant recipient. Clin Transplant 1996, 10:503
28. el-Gebely S, Hathaway DK, Elmer DS, et al: An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation. Transplantation 1995, 59:1410
29. Steffes MW: Glomerular lesions of diabetes mellitus: preventable and reversible. Nephrol Dial Transplant 1999, 14:19
30. Fioretto P, Steffes MW, Sutherland DE, et al: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69
31. Koznarova R, Saudek F, Sosna T, et al: Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000, 9:903
32. Scheider A, Meyer-Schwickerath E, Nusser J, et al: Diabetic retinopathy and pancreas transplantation: A 3-year follow-up. Diabetologia 1991, 34:S95 (suppl)
33. Giannarelli R, Coppelli A, Sartini MS, et al: Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. Diabetes Care 2002, 25:2358
34. Matas AJ, McHugh L, Payne WD, et al: Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplant 1998, 12:233
35. Gross CR, Limwattananon C, Matthees BJ: Quality of life after pancreas transplantation: a review. Clin Transplant 1998, 12:351
36. Gross CR, Limwattananon C, Matthees B, et al: Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 2000, 70:1736
37. Light JA, Sasaki TM, Currier CB, et al: Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 2001, 71:152
38. Gruessner RW, Manivel C, Dunn DL, et al: Pancreaticoduodenal transplantation with enteric drainage following native total pancreatectomy for chronic pancreatitis: A case report. Pancreas 1991, 6:479
39. Schweitzer EJ, Anderson L, Kuo PC, et al: Safe pancreas transplantation in patients with coronary artery disease. Transplantation 1997, 63:1294
40. Network. OPaT. Available at: URL:www.optn.org. Accessed Aug 28, 2003.
41. Krieger NR, Becker BN, Heisey DM, et al: Chronic allograft nephropathy uniformly affects recipients of cadaveric, non-identical living-related, and living-unrelated grafts. Transplantation 2003, 75:1677
42. Van der Werf WJ, Odorico J, D'Alessandro AM, et al: Utilization of pediatric donors for pancreas transplantation. Transplant Proc 1999, 31:610
43. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al: Successful extrarenal transplantation from non-heart-beating donors. Transplantation 1995, 59:977
44. D'Alessandro AM, Odorico JS, Knechtle SJ, et al: Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). Cell Transplant 2000, 9:889
45. Tojimbara T, Teraoka S, Babazono T, et al: Long-term outcome after combined pancreas and kidney transplantation from non-heart-beating cadaver donors. Transplant Proc 1998, 30:3793
46. Kapur S, Bonham CA, Dodson SF, et al: Strategies to expand the donor pool for pancreas transplantation. Transplantation 1999, 67:284
47. Gruessner RW, Kendall DM, Drangstveit MB, et al: Simultaneous pancreas-kidney transplantation from live donors. Ann Surg 1997, 226:471
48. Troisi R, Meester D, Regaert B, et al: Physiologic and metabolic results of pancreatic cold storage with Histidine-Tryptophan-Ketoglutarate-HTK solution (Custodiol) in the porcine autotransplantation model. Transpl Int 2000, 13:98
49. Hiraoka K, Kuroda Y, Suzuki Y, et al: Outcomes in clinical pancreas transplantation with the two-layer cold storage method versus simple storage in University of Wisconsin solution. Transplant Proc 2002, 34:2688
50. Rayhill SC, D'Alessandro AM, Odorico JS, et al: Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: Is there a difference in survival? Ann Surg 2000, 231:417
51. Gruessner RW, Dunn DL, Tzardis PJ, et al: Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: Comparison of rejection, morbidity, and long-term outcome. Transplant Proc 1990, 22:622
52. Gruessner AC, Sutherland DE, Dunn DL, et al: Pancreas after kidney transplants in posturemic patients with type I diabetes mellitus. J Am Soc Nephrol 2001, 12:2490
53. Gruessner RW, Sutherland DE, Najarian JS, et al: Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. Transplantation 1997, 64:1572
54. Schweitzer EJ, Bartlett ST: Wound complications after pancreatic transplantation through a kidney transplant incision. Transplant Proc 1994, 26:461
55. Prieto M, Sutherland DE, Fernandez-Cruz L, et al: Experimental and clinical experience with urine amylase monitoring for early diagnosis of rejection in pancreas transplantation. Transplantation 1987, 43:73
56. Van der Werf WJ, Odorico JS, D'Alessandro AM, et al: Enteric conversion of bladder-drained pancreas allografts: Experience in 95 patients. Transplant Proc 1998, 30:441
57. West M, Gruessner AC, Metrakos P, et al: Conversion from bladder to enteric drainage after pancreaticoduodenal transplantations. Surgery 1998, 124:883
58. Diem P, Abid M, Redmon JB, et al: Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990, 39:534
59. Pfeffer F, Nauck MA, Erb M, et al: Absence of severe hyperinsulinemia after pancreas/kidney transplantation with peripheral venous drainage. Transplant Proc 1997, 29:645
60. Ost L, Tyden G, Fehrman I: Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation 1988, 46:370
61. Katz H, Homan M, Velosa J, et al: Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 1991, 325:1278
62. Christiansen E, Vestergaard H, Tibell A, et al: Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover. Diabetes 1996, 45:1267
63. Boden G, Chen X, Ruiz J, et al: Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation. J Clin Endocrinol Metab 1994, 78:657
64. Abe H, Bandai A, Makuuchi M, et al: Hyperinsulinaemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas. Diabetologia 1996, 39:1276
65. Fontbonne A, Charles MA, Thibult N, et al: Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991, 34:356
66. Inchiostro S, Bertoli G, Zanette G, et al: Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease. Diabetologia 1994, 37:597
67. Despres JP, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952
68. Foger B, Konigsrainer A, Palos G, et al: Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. Transplantation 1994, 58:899
69. Konigsrainer A, Foger BH, Miesenbock G, et al: Pancreas transplantation with systemic endocrine drainage leads to improvement in lipid metabolism. Transplant Proc 1994, 26: 501
70. Bagdade JD, Teuscher AU, Ritter MC, et al: Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation. Diabetes 1998, 47:113
71. Bagdade JD, Ritter MC, Kitabchi AE, et al: Differing effects of pancreas-kidney transplantation with systemic versus portal venous drainage on cholesteryl ester transfer in IDDM subjects. Diabetes Care 1996, 19:1108
72. Christiansen E, Roder M, Tibell A, et al: Effect of pancreas transplantation and immunosuppression on proinsulin secretion. Diabet Med 1998, 15:739
73. Stratta RJ, Shokouh-Amiri MH, Egidi MF, et al: A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage. Ann Surg 2001, 233:740
74. Holman JM Jr, Todd R: Enhanced survival of heterotopic rat heart allografts with portal venous drainage. Transplantation 1990, 49:229
75. Yang R, Liu Q, Grosfeld JL, et al: Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J Pediatr Surg 1994, 29:1145
76. Liu H, Teraoka S, Kawai T, et al: Comparative evaluation of systemic vs portal venous drainage in long-term surviving rats with orthotopic small bowel transplantation. Transplant Proc 1992, 24:1505
77. Humar A, Kandaswamy R, Granger D, et al: Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000, 231:269
78. Sollinger HW: Pancreatic transplantation and vascular graft thrombosis. J Am Coll Surg 1996, 182:362
79. Odorico JS, Pirsch JD, Knechtle SJ, et al: A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998, 66:1751
80. Tesi RJ, Henry ML, Elkhammas EA, et al: The frequency of rejection episodes after combined kidney-pancreas transplant- the impact on graft survival. Transplantation 1994, 58:424
81. Kaufman DB, Leventhal JR, Koffron A, et al: Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. Surgery 2000, 128:726
82. Stegall MD, Simon M, Wachs ME, et al: Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Transplantation 1997, 64:1695
83. Gruessner RW, Sutherland DE, Drangstveit MB, et al: Mycophenolate mofetil in pancreas transplantation. Transplantation 1998, 66:318
84. Merion RM, Henry ML, Melzer JS, et al: Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Transplantation 2000, 70:105
85. Ciancio G, Lo Monte A, Buscemi G, et al: Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation. Transpl Int 2000, 13(Suppl 1):S191
86. Rigotti P, Cadrobbi R, Baldan N, et al: Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: A single-center experience. Clin Nephrol 2000, 53:52
87. Kaufman DB, Leventhal JR, Stuart J, et al: Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: Initial experience in 50 consecutive cases. Transplantation 1999, 67:586
88. Stratta RJ, Alloway RR, Lo A, et al: Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: Primary endpoint analysis of a multicenter, randomized study. Transplantation 2003, 75:1260
89. Tan M, Cantarovich M, Mangel R, et al: Reduced dose thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes. Clin Transplant 2002, 16:414
90. Stratta RJ, Lo A, Shokouh-Amiri MH, et al: Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int 2003, 16:154
91. Kahan BD, Julian BA, Pescovitz MD, et al: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: A phase II trial. Rapamune Study Group. Transplantation 1999, 68:1526
92. Salazar A, McAlister VC, Kiberd BA, et al: Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: Effect on renal function. Transplant Proc 2001, 33:1038
93. Knight RJ, Kerman RH, Zela S, et al: Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Transplantation 2003, 75:1301
94. MacDonald S, Kiberd B, Salazar A, et al: Rapamycin and low-dose tacrolimus in kidney-pancreas transplants: a 12-36 month follow-up. Am J Transplant 2002, 2(Suppl 3):141 (abstr)